Key result
Viral-based myocardial gene therapy offers promising novel benefits for human ischemic heart disease and potential future therapeutic benefits in heart failure by improving cardiac function.
Viral-based gene therapy represents a promising approach to correct molecular derangements and improve cardiac function in ischemic heart disease and heart failure.
No takes yet. Share an insight, caveat, or question.
Remains investigational for ischemic heart disease and heart failure; leaves open clinical adoption pending randomized trials.
Williams et al. (2004) conducted a review in Cardiac disease. Viral-based myocardial gene therapy was evaluated. Viral-based myocardial gene therapy offers promising novel benefits for human ischemic heart disease and potential future therapeutic benefits in heart failure by improving cardiac function.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: